Related Experiment Videos

Amoxycillin-clavulanic acid (Augmentin) versus metronidazole as prophylaxis in hysterectomy: a prospective,

E M Brown1, J Depares, A A Robertson

  • 1University Hospital of Wales, Heath Park, Cardiff.

British Journal of Obstetrics and Gynaecology
|March 1, 1988
PubMed

Insights

Amoxycillin-clavulanic acid significantly reduced infectious morbidity after hysterectomy compared to metronidazole. This antibiotic regimen is effective for preventing surgical site infections in women undergoing hysterectomy.

Area of Science:

  • Infectious Diseases
  • Surgical Prophylaxis
  • Pharmacology

Background:

  • Elective hysterectomy carries a risk of postoperative infection.
  • Optimizing prophylactic antibiotic regimens is crucial for patient outcomes.

Purpose of the Study:

  • To compare the efficacy of amoxycillin-clavulanic acid versus metronidazole for preventing infection after elective hysterectomy.
  • To identify the most effective perioperative antibiotic prophylaxis.

Main Methods:

  • A randomized trial involving 300 patients undergoing elective hysterectomy.
  • Patients received either intravenous amoxycillin-clavulanic acid (1.2 g) or a metronidazole (1 g) suppository perioperatively.
  • Infectious morbidity, operative site infections, and hospital stay were assessed.

Main Results:

  • Amoxycillin-clavulanic acid group had significantly lower infectious morbidity (13.8%) compared to the metronidazole group (33.1%).
  • Reduced rates of operative site infection, shorter hospital stays, and fewer postoperative antimicrobial needs were observed with amoxycillin-clavulanic acid.
  • Pathogen analysis indicated amoxycillin-clavulanic acid's effectiveness against both aerobic and anaerobic bacteria.

Conclusions:

  • Amoxycillin-clavulanic acid is a safe and effective prophylactic agent for preventing infection after hysterectomy.
  • Prophylaxis should target both aerobic and anaerobic bacteria, a criterion met by amoxycillin-clavulanic acid.

Related Concept Videos